Search

Issue
Title
Authors
The role of menopausal hormone therapy in the prevention of type 2 diabetes melltus in postmenopausal women
Apetov S.S., Apetova V.V.
School of diabetes: new education module on insulin pump for patients with type 1 diabetes mellitus
Lisker A.V., Volkova A.R., Chernaya M.E., Mozgunova V.S., Durdyeva M.B.
Experience of using the new ultrafast-acting insulin Fiasp® in patients on insulin pump therapy: a case report
Barsukov I.A., Demina A.A.
Predictors of severe course of disease and high mortality among patients with COVID-19 and diabetes mellitus
Ivanova M.Z., Zhurtova I.B., Sizhazheva S.K., Gubachikova A.M.
Resistin levels and metabolic parameters in patients type 2 diabetes mellitus in combination with hypothyroidism
Verbovoy T.V., Lomonova T.V.
Features of the treatment of patients with type 2 diabetes mellitus and morbid obesity
Amosova M.V., Gurova O.Y., Fadeev V.V.
Start of therapy of type 2 diabetes mellitus with a fixed combination. Metformin with vildagliptin or glibenclamide, is there any difference?
Demidov N.A., Koteshkova O.M., Balberova M.A., Antsiferov M.B.
The place of glyflozins in the management of type 2 diabetes mellitus
Sharonova L.A., Verbovoy A.F.
Diabetic autonomic neuropathy: problems of diagnosis and therapy
Kurnikova I.A., Yurovsky A.Y.
Alogliptin in the treatment of type 2 diabetes mellitus: an evidence base for the clinical use
Biryukova E.V.
Disturbances of the autonomic innervation of the cardiovascular system and hemostasis: their role in the change of microcirculation in patients with type 2 diabetes mellitus
Tsvetkova I.G., Kaukova A.N., Belyakova N.A., Vasyutkova O.A., Konovalova O.V., Lareva A.V.
Therapy with nonsteroid antiinflammatory drugs in patients with acute nonspecific low back pain: dynamics of renal function: results of «PANDA» cogort study
Zolotovskaya I.A., Davydkin I.L., Borovkova N.Y.
SELF-CONTROL OF GLYCEMIA: SHELFLIFE OF TEST STRIPS IS IMPORTANT
Biryukova E.V.
Diabetes mellitus and coronary artery disease: features of clinical manifestation and treatment
Verbovoy A.F., Sharonova L.A.
INCRETIN SYSTEM AS PROMISING PHARMACOLOGICAL TARGET FOR HYPOGLYCEMIC THERAPY
Kurkin D.V., Volotova E.V., Bakulin D.A., Lomkina E.M., Tyurenkov I.N.
Adipokiny i gormonal'no-metabolicheskie pokazateli u bol'nykh sakharnym diabetom 2 tipa i podagroy
Verbovoy A.F., Tsanava I.A., Verbovaya N.I.
NEBIVOLOL V LEChENII ARTERIAL'NOY GIPERTENZII U BOL'NYKh VYSOKOGO RISKA
Minushkina L.O.
Analiz effektivnosti i bezopasnosti primeneniya otechestvennogo insulina Rinsulin NPKh v gorode Nizhniy Novgorod
Zanozina O.V., Sorokina Y.A., Lovtsova L.V., Borovkov N.N.
UPRAVLENIE SAKhARNYM DIABETOM: ZNAChENIE STRUKTURIROVANNOGO SAMOKONTROLYa
Antsiferov M.B., Koteshkova O.M.
TERAPIYa LIRAGLUTIDOM ZNAChITEL'NO ULUChShAET KONTROL' GLIKEMII I OKAZYVAET POLOZhITEL'NOE VLIYaNIE NA SERDEChNO-SOSUDISTUYu SISTEMU PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA
Kudinov V.I., Nichitenko M.S., Chesnikova A.I.
Bazal'naya insulinoterapiya: opyt klinicheskoy praktiki
Chernikova N.A., Ametov A.S., Antsiferov M.B.
PREIMUShchESTVA METFORMINA PROLONGIROVANNOGO DEYSTVIYa
Petunina N.A., Trukhina L.V., Sinitsyna E.I., Antsiferov M.B.
REGIDRATATsIONNAYa TERAPIYa I VOZMOZhNOSTI EE KONTROLYa U PATsIENTOV S DIABETIChESKIMI KOMAMI (OBZOR LITERATURY)
Legun A.V., Vetsheva M.S.
Mnogofaktornoe upravlenie sakharnym diabetom 2 tipa: kakovy nashi segodnyashnie vozmozhnosti
Galstyan G.R.
Osobennosti lecheniya narusheniy tolerantnosti k glyukoze u patsientov s abdominal'no-vistseral'nym tipom ozhireniya na rannikh etapakh ego razvitiya
Shilov A.M., Abdullaeva A.T.
DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M.B., Antsiferov M.B.
SULFONYLUREAS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS TODAY. IS THERE A PROSPECT?
Kononenko I.V., Smirnova O.M., Smirnova O.M., Kononenko I.V.
DIABETES INSIPIDUS IN CHILDREN
Strebkova N.A., Pisareva E.A., Strebkova N.A., Pisaryova E.A.
SAXAGLIPTIN (ONGLYZA ®) IN CONCEPTION OF EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Petunina N.A., Brashchenkova A.V., Petunina N.A., Brashcenkova A.V.
CURRENT APPROACHES TO THERAPY TYPE 2 DIABETES - EFFECT ON INSULIN RESISTANCE
Shishkova V.N., Shishkova V.N.
PHARMACOECONOMIC ASPECTS OF USE OF SULFONYLUREA MEDICATIONS IN INSULIN-INDEPENDENT DIABETES
Rudakova A.V., Rudakova A.V.
AUTONOMIC NEUROPATHY IN DIABETES MELLITUS: CLINICAL MANIFESTATIONS, DIAGNOSIS AND TREATMENT
Barinov A., Novosadova M., Barinov A.N., Novosadova M.V.
New possibilities for diabetic peripheral neuropathy treatment
Komelyagina E.Y., Antsiferov M.B., Komelyagina E., Antsiferov M.
Disturbances of lipid metabolism in pregnancy
Tkacheva O.N., Galyautdinova A.Y., Prokhorovich E.A., Mishina I.E., Torshkhoeva K.M., Tkacheva O.N., Galjautdinova A.Y., Prochorovich E.A., Mishina I.E., Torshchoeva C.M.
Metformin - pathogenetic drug of first-line in the treatment of type 2 diabetes
Zilov A.V., Zilov A.V.
Variant of development of comorbid condition with late diagnosis of pancreatogenic diabetes mellitus: clinical case
Kudinova E.V., Davidenko I.Y., Volkova N.I.
Evaluation of non-glycemic effects of a fixed combination of alogliptin and pioglitazone
Elsukova O.S., Nikitina E.A.
Analysis of the prognostic quality of mortality predictors in patients with COVID-19 and comorbid background: a retrospective study
Aramisova L.S., Zhurtova I.B., Khachmakhova E.Z.
Possibilities of using a fixed combination of alogliptin and pioglitazone in patients with type 2 diabetes mellitus in everyday clinical practice
Elsukova O.S., Nikitina E.A., Chuprova A.V., Kaysina O.A.
Modern and safe treatment of type 2 diabetes mellitus. Clinical case of the use of gozogliptin in the treatment of a patient with decompensated diabetes mellitus
Smirnova E.Y.
Biochemical markers of various subtypes of gestational diabetes
Volkova N.I., Degtyareva Y.S., Davidenko I.Y., Degtyareva Y.S., Avrutskaya V.V.
Pharmacotherapeutic aspects of gestational diabetes mellitus against the background of impaired maternal immunity
Kazimova A.U., Polukhova S.M.
Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination
Biryukova E.V., Shinkin M.V., Morozova I.A.
Vildagliptin - new opportunities in the treatment of type 2 diabetes mellitus
Pavlova M.G.
P-cell dysfunction in type 2 diabetes mellitus: the possibilities of modern antihyperglycemic therapy
Chernikova N.A.
New possibilities of using the FreeStyle Libre Flash-glucose monitoring system. FreeStyle Libre software ecosystem in Russia
Demidov N.A.
The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine
Kochetkov A.I., Pereverzev A.P., Ostroumova O.D., Gusenbekova D.G., Romanovsky R.R., Shatalova N.A.
Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study
Mkrtumyan A.M., Vorobyev S.V., Volkova A.R., Vorokhobina N.V.
Is it possible to stop the diabetes epidemic?
Verbovoy A.F., Dolgikh Y.A., Verbovaya N.I.
Statins and the risk of diabetes: an evidence-based review
Leonova M.V.
Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia
Pereverzev A.P., Ostroumova O.D., Tkacheva O.N.
Genetic predictors of the pharmacological effects of dipeptidyl peptidase-4 inhibitors and sulfonylureas in patients with type 2 diabetes mellitus
Shorokhova P.B., Baranov V.L., Vorokhobina N.V., Shpilevaya O.S.
Potentials for the management of cardiovascular risk in diabetic patients on insulin therapy
Galstyan G.R., Antsiferov M.B., Alekseeva Y.G.
Advantages of switch to premixed insulin degludec/aspart in patients with type 2 diabetes mellitus who have not achieved an optimal control with previous insulin therapy
Elsukova O.S., Sobolev A.A.
POTENTIALS FOR THE DRUG CORRECTION OF SECONDARY MITOCHONDRIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND COMORBID PATHOLOGY
Statsenko M.E., Turkina S.V., Tyshchenko I.A., Fabritskaya S.V., Poletaeva L.V.
EFFICIENCY AND SAFETY OF USE OF CANAGLIFLOZIN IN THE OUTPATIENT PRACTICE
Demidov N.A., Antsiferov M.B., Dorofeeva L.G.
Metabolic syndrome and intestinal microbiota
Egshatyan L.V., Mkrtumyan A.M., Zvenigorodskaya L.A.
APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS
Antsiferov M.B.
Gipoglikemiya i kachestvo zhizni bol'nykh sakharnym diabetom 2 tipa
Antsiferov M.B., Nikitina T.P., Rodionova A.Y., Kurbatova K.A., Ionova T.I.
Effektivnost' trekhkomponentnoy terapii s ispol'zovaniem liraglutida (Viktoza) -pervogo analoga glyukagonopodobnogo peptida-1 dlitel'nogo deystviya - u patsientov s sakharnym diabetom 2 tipa i vistseral'nym ozhireniem
Antsiferov M.B., Koteshkova O.M.
Primenenie Aktovegina kak universal'nyy metod lecheniya oslozhneniy sakharnogo diabeta
Meleshkevich T.A., Luchina E.I., Lukashova M.E.
Fiksirovannaya kombinatsiya saksagliptina i metformina modifitsirovannogo vysvobozhdeniya - novyy shag v uluchshenii priverzhennosti k lecheniyu sakharnogo diabeta 2 tipa
Biryukova E.V.
KLINIKA, DIAGNOSTIKA I LEChENIE DIABETIChESKOY NEYROPATII
Sharonova L.A., Verbovoy A.F., Sharonova D.Y.
Osnovnye printsipy lecheniya nesakharnogo diabeta u detey
Strebkova N.A.
Novyy klass antidiabeticheskikh preparatov - ingibitory natriy-glyukoznykh kotransporterov
Ushkalova E.A.
PERSPEKTIVNYE STRATEGII V LEChENII DIABETIChESKOY POLINEVROPATII: ROL' ANTIOKSIDANTNOY TERAPII
Gur'eva I.V., Svetlova O.V.
O RATsIONAL'NOM VYBORE FARMAKOTERAPII PRI SAKhARNOM DIABETE 2 TIPA
Biryukova E.V.
Algoritmy spetsializirovannoy meditsinskoy pomoshchi bol'nym sakharnym diabetom 2011 g.: osnovnye izmeneniya
Mayorov A.Y.
PATIENT WITH DIABETES INSIPIDUS - POLYURIA: YESTERDAY, TODAY AND TOMORROW
Doskina E.V., Doskina Y.V.
APPLICATION OF VILDAGLIPTIN IN COMBINATION WITH INSULIN IN TYPE 2 DIABETES MELLITUS
Antsiferov M.B., Antsiferov M.B.
Insulin pump - advanced menu of experienced user
Arbatskaya N.Y., Arbatsraya N.Y.
CLINICAL AND METABOLIC EFFICIENCY OF DRUG DIBIKOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Severina T.I., Popkova E.N., Trel'skaya N.Y., Emel'yanov V.V., Severina T.I., Popkova Y.N., Trelskaya N.Y., Yemelyanov V.V.
COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N.A., Trukhina L.V., Petunina N.A., Truhina L.V.
ROLE OF SPECIALIZED NUTRITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL EXPERIENCE OF USING OF GLUCERNA SR
Antsiferov M.B., Morgunov L.Y., Antsiferov M.B., Morgunov L.Y.
ADIPONECTIN AND C-REACTIVE PROTEIN AS FACTORS OF CARDIOVASCULAR RISK IN MEN WITH TYPE 2 DIABETES MELLITUS
Morkovskikh N., Morkovskikh N.V.
Advance - movement forward
Petunina N.A., Petunina N.
Bisoprolol in therapy of arterial hypertension and ischemic heart disease
Kirichenko A.A., Kirichenko A.A.
Experience of incritinomimetic exenatide (Byetta) use in the treatment of patients with type 2 diabetes mellitus with obesity
Antsiferov M.B., Koteshkova O.M., Sitnikov V.V., Mityaeva O.A., Pashintseva L.P., Budantseva T.A., Ivanova E.A., Anciferov M.B., Koteshkova O.M., Sitnikov V.V., Mityaeva O.A., Pashinceva L.P., Budanceva T.A., Ivanova E.A.
Efficacy of gosogliptin in the treatment of type 2 diabetes mellitus: a clinical case
Smirnova E.Y.
Efficacy and safety of the Russian GLP-1 receptor agonist Quincenta (semaglutide) in patients with type 2 diabetes mellitus in real clinical practice (QUINPROMIS study. Interim data)
Antsiferov M.B., Koteshkova O.M., Antsiferova D.M., Romashkina L.P., Golubeva Y.V.
Intestinal microbiota status in patients with type 2 diabetes mellitus depending on the presence of chronic pyelonephritis at pre-dialysis stages of chronic kidney disease – an observational case-control study
Sturov N.V., Popov S.V., Kobalava Z.D., Belikov I.I., Zhukov V.A., Lyapunova T.V., Meleshkevich T.A.
Modern aspects of detection and monitoring of preclinical stages of type 1 diabetes mellitus in children
Varlamova T.V., Vezikova N.N.
Cohort study of clinical and anamnestic characteristics of patients with a combination of type 2 diabetes mellitus and irritable bowel syndrome
Suprun O.E., Bagriy A.E., Mikhailichenko E.S., Andreeva E.A., Evtushenko A.A., Suprun E.V.
Intensification of glucose-lowering therapy for type 2 diabetes mellitus using insulin degludec: clinical case analysis
Elsukova O.S.
Modern possibilities for assessing glycemia in diabetic patients
Chernikova N.A., Degtyareva E.I.
Possibilities of using trimetazidine in comorbid cardiovascular pathology and metabolic disorders
Nikiforov V.S.
Features of the pathogenesis and treatment of diabetes mellitus during the COVID-19 pandemic
Bagriy A.E., Mikhailichenko E.S., Prikolota A.V., Mogilevskaya K.E.
Problem of treatment adherence in patients with type 2 diabetes mellitus
Akulova A.D., Zhulina Y.S., Rozhkova V.V., Martynova E.Y., Poteshkin Y.E.
Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus
Antsiferov M.B., Koteshkova O.M., Novikova M.S., Demidov N.A.
What should the practitioner remember when managing patients with diabetic neuropathy
Isakova E.V., Kotov S.V.
Combination of two hypoglycemic drugs for type 2 diabetes mellitus
Morgunova T.B., Fadeyev V.V.
Does autoimmune thyroiditis affect the clinical course of type 1 diabetes mellitus in children, regardless of the functional state of the thyroid gland?
Abdullaev A.N., Litvinova D.V., Rozhkov N.I., Kiyaev A.V.
Hypoglycemic drugs and drug-induced heart failure
Ostroumova O.D., Goloborodova I.V.
Prevention of blindness in diabetes mellitus. From retinal laser coagulation to pharmacology
Shadrichev F.E., Demidova T.Y., Grigorieva N.N., Kozhevnikov A.A.
Poststroke recovery in patients with type 2 diabetes mellitus
Tanashyan M.M., Maksimova M.Y., Antonova K.V., Raskurazhev A.A., Shakhparonova N.V., Romantsova T.I.
ASSESSMENT OF THE EFFICACY AND SAFETY OF INSULIN DEGLUDEC IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS IN REAL-LIFE CLINICAL PRACTICE
Kiyaev A.V., Kondrashova O.E., Chernykh L.G., Pollyak O.Y., Yusupova A.R., Slovak M.A., Zaykova I.O.
Effect of SGLT-2 inhibitors on cardiovascular outcomes: review of results of CVD-REAL trial
Antsiferov M.B.
THE USE OF ANTIBACTERIAL DRUGS DURING ORTHOPAEDIC ALIGNMENT WITH REMOVABLE LAMINAR DENTURES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TAKING INTO ACCOUNT THE RESULTS OF PCR-BASED DIAGNOSTICS
Shevkunova N.A.
SAFE AND EFFECTIVE COMBINATION OF ULTRALONG-ACTING BASAL INSULIN DEGLUDEC AND ULTRA-SHORT ACTING INSULINE ASPART IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
Girsh Y.V., Veliyeva O.A.
Current approaches to therapy of type 2 diabetes mellitus in the era of new data on cardiovascular safety
Antsiferov M.B., Schernthaner G.
201 - 300 of 363 Items << < 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"